COCRYSTAL PHARMA INC (COCP) Stock Cash Flow
NASDAQ:COCP - Nasdaq - US19188J4094 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -15.85M | -17.50M | -17.98M | -38.84M | -14.19M | |||
| Depreciation Amortization | 111.00K | 126.00K | 189.00K | 190.00K | 190.00K | |||
| Income Taxes - Deferred | N/A | N/A | N/A | N/A | N/A | |||
| Change In Working Capital | 308.00K | 140.00K | 2.34M | -2.71M | 600.00K | |||
| Other non cash items | 626.00K | 753.00K | 787.00K | 19.93M | 670.00K | |||
| OPERATING CASH FLOW | -14.81M | -16.48M | -14.67M | -21.44M | -12.72M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | 2.00K | -8.00K | -118.00K | -70.00K | -50.00K | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | 2.00K | -8.00K | -118.00K | -70.00K | -50.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | -7.00K | -30.00K | -40.00K | |||
| Stock Issued/Repurchased | N/A | N/A | 4.00M | 0.00 | 38.51M | |||
| FINANCING CASH FLOW | N/A | N/A | 3.99M | -30.00K | 38.47M | |||
| CHANGE IN CASH | -14.92M | -16.49M | -10.79M | -21.54M | 25.70M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -14.81M | -16.48M | -14.67M | -21.44M | -12.72M | |||
| Capital Expenditure | 2.00K | -8.00K | -118.00K | -70.00K | -50.00K | |||
| FREE CASH FLOW | -14.81M | -16.49M | -14.78M | -21.51M | -12.77M | |||
All data in USD